Skip to main content
Back to Investors

Oxford Science Enterprises Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Oxford Science Enterprises Investment Overview

Portfolio Companies
100
Total Invested
$1.3B
Average Investment
$20.4M

Oxford Science Enterprises's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
Caristo Diagnostics2024Venture - Series Unknown$150KOxford
Greywolf Therapeutics2024Series B$50.0MAbingdon
Oxford Endovascular2024Series A$10.2MOxford
Proxisense2023Series A$1.3MOxford
Prolific2023Series A$32.3MOxford
OMass Therapeutics2023Series B$12.5MOxford
Quantrol Ox2023Seed$3.7MEspoo
Beacon Therapeutics2026Series C$75.0MAlachua
Albus Health2023Venture - Series UnknownUndisclosedOxford
Alethiomics2021SeedUndisclosedHeadington

Complete List of Oxford Science Enterprises Portfolio Companies (100)

Export
#CompanyStageAmountLocation
26Caristo DiagnosticsVenture - Series Unknown$150KOxford, United Kingdom
27Greywolf TherapeuticsSeries B$50.0MAbingdon, United Kingdom
28Oxford EndovascularSeries A$10.2MOxford, United Kingdom
29ProxisenseSeries A$1.3MOxford, United Kingdom
30ProlificSeries A$32.3MOxford, United Kingdom
31OMass TherapeuticsSeries B$12.5MOxford, United Kingdom
32Quantrol OxSeed$3.7MEspoo, Finland
33Beacon TherapeuticsSeries C$75.0MAlachua, United States
34Albus HealthVenture - Series UnknownUndisclosedOxford, United Kingdom
35AlethiomicsSeedUndisclosedHeadington, United Kingdom
BiopharmaHealth CareHealth DiagnosticsMedical Device

Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.

Oxford, United Kingdom
September 2024
$150K
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

Abingdon, United Kingdom
May 2024
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

Oxford, United Kingdom
May 2024
$10.2M
Series A

Founder Contacts

19,000+ verified contacts

HardwareSensor

Proxisense has developed extreme environment proximity sensors and fluid contamination systems.

Oxford, United Kingdom
November 2023
$1.3M
Series A

Founder Contacts

19,000+ verified contacts

CrowdsourcingMarket ResearchProduct ResearchPsychology

Building the most advanced global infrastructure for People Science.

Oxford, United Kingdom
July 2023
$32.3M
Series A

Founder Contacts

19,000+ verified contacts

Life SciencePharmaceutical

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Oxford, United Kingdom
May 2023
$12.5M
Series B

Founder Contacts

19,000+ verified contacts

Information TechnologyMachine LearningQuantum ComputingSoftware

QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.

Espoo, Finland
March 2023
$3.7M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

Alachua, United States
January 2026
$75.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth CareHealth DiagnosticsHome Health CareMedicalMedical Device

A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.

Oxford, United Kingdom
December 2023
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.

Headington, United Kingdom
December 2021
Seed

Founder Contacts

19,000+ verified contacts

Autonomous VehiclesDronesLogisticsMachinery ManufacturingProduct ResearchSecurity

Animal Dynamics Ltd, based in Oxford, UK, is a technology company specialising in the design and manufacture of autonomous vehicles.

Oxford, United Kingdom
January 2022
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedical DeviceWellness

Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.

Oxford, United Kingdom
November 2024
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Scripta Therapeutics operates as a bio-tech company.

Oxford, United Kingdom
November 2025
$12.0M
Seed

Founder Contacts

19,000+ verified contacts

AgricultureArtificial Intelligence (AI)Computer VisionHealth CareImage RecognitionInformation TechnologyMachine LearningRemote SensingSecuritySoftware

Living Optics is an imaging technology company.

Abingdon, United Kingdom
October 2022
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

Oxford, United Kingdom
March 2026
$9.3M
Grant

Founder Contacts

19,000+ verified contacts

AI InfrastructureArtificial Intelligence (AI)HardwareSemiconductor

Fractile is building chips that remove every bottleneck to running large language models at a global scale

London, United Kingdom
January 2026
$22.5M
Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareHealth Diagnostics

Allos is a solution to prognose, monitor, and treat autoimmune conditions.

London, United Kingdom
January 2026
$5.0M
Seed

Founder Contacts

19,000+ verified contacts

AerospaceLaserOptical CommunicationSatellite Communication

Archangel Lightworks builds deployable laser communication systems for the space-enabled networks of the future.

London, United Kingdom
November 2025
$466K
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

Valink Therapeutics develops drug discovery programs focused on bispecific antibody-drug conjugates designed for complex disease biology.

London, United Kingdom
October 2025
$11.8M
Seed

Founder Contacts

19,000+ verified contacts

AgTechBiotechnologySustainability

Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.

Oxford, United Kingdom
October 2025
$60.5M
Series A

Founder Contacts

19,000+ verified contacts

Health CareNeuroscience

Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.

London, United Kingdom
October 2025
$5.6M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareHospital

Oath Surgical operates with distinction, offering our patients, associates, and partners unmatched value and experiences.

San Francisco, United States
October 2025
$24.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Data CenterIT InfrastructureMachine LearningSensorSoftware

Salience Labs provides photonic switch technology and optical networking solutions tailored for AI infrastructure.

Oxford, United Kingdom
September 2025
Series Unknown

Founder Contacts

19,000+ verified contacts

ChemicalManufacturing

FluoRok is revolutionizing the way fluorochemicals are produced globally.

Oxford, United Kingdom
August 2025
$2.0M
Grant

Founder Contacts

19,000+ verified contacts

ArchitectureConstructionSmart Building

NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality.

Oxford, United Kingdom
May 2025
$4.5M
Seed

Founder Contacts

19,000+ verified contacts

Showing 26-50 of 100 portfolio companies

Frequently Asked Questions About Oxford Science Enterprises

How many companies has Oxford Science Enterprises invested in?

Oxford Science Enterprises has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Oxford Science Enterprises invest in?

Oxford Science Enterprises's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 49 different industry categories.

What is Oxford Science Enterprises's largest investment?

Among tracked funding rounds, Beacon Therapeutics received $75.0M in a Series C round. Oxford Science Enterprises's total known invested capital is $1.3B.

What is the average investment size for Oxford Science Enterprises?

Oxford Science Enterprises's average investment size is $20.4M across its portfolio of 100 companies.

What are Oxford Science Enterprises's most recent investments?

Recent Oxford Science Enterprises portfolio additions include Caristo Diagnostics, Greywolf Therapeutics, Oxford Endovascular, Proxisense, Prolific. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors